> The FDA is examining a handful of cases in which men taking Viagra have gone blind. The agency says that there is currently no known link, but that it will investigate. Story
> Roche has received European marketing approval for 500 mg formulation of the HIV drug Invirase. Story
> The FDA has approved Abbott's Zemplar (paricalcitol) for the prevention and treatment of secondary hyperparathyroidism. Release
> The FDA has approved Novartis Pharmaceuticals' extended release form of Focalin for ADHD, which is licensed from Celgene. Story
> Ariad has begun its first clinical trial of oral AP23573 in patients with relapsed or refractory cancers. Release
> NovaDel Pharma of Flemington, New Jersey, raised $7 million in a private placement. Release
> Santarus has filed an NDA for Zegerid chewable tablets. Release
> King Pharmaceuticals and Astellas have filed suit against several generic drug makers following their ANDA for Adenoscan, a pharmacologic stress agent. Release
And Finally... A group of scientists is challenging new research claiming that people who are slightly overweight live longer. Story